前往化源商城

Journal of Dental Research 2008-06-01

Clinically relevant cell sources for TMJ disc engineering.

D E Johns, M E Wong, K A Athanasiou

文献索引:J. Dent. Res. 87 , 548-52, (2010)

全文:HTML全文

摘要

Tissue-engineering of the temporomandibular joint (TMJ) disc aims to provide patients with TMJ disorders an option to replace diseased tissue with autologous, functional tissue. This study examined clinically relevant cell sources by comparing costal chondrocytes, dermal fibroblasts, a mixture of the two, and TMJ disc cells in a scaffoldless tissue-engineering approach. It was hypothesized that all constructs would produce matrix relevant to the TMJ disc, but the mixture constructs were expected to appear most like the TMJ disc constructs. Costal chondrocyte and mixture constructs were morphologically and biochemically superior to the TMJ disc and dermal fibroblast constructs, and their compressive properties were not significantly different. Costal chondrocyte constructs produced almost 40 times more collagen and 800 times more glycosaminoglycans than did TMJ constructs. This study demonstrates the ability of costal chondrocytes to produce extracellular matrix that may function in a TMJ disc replacement.

相关化合物

结构式 名称/CAS号 全部文献
抗坏血酸 结构式 抗坏血酸
CAS:50-81-7
弹性蛋白酶,来源猪胰腺 结构式 弹性蛋白酶,来源猪胰腺
CAS:39445-21-1
胰岛素(人) 结构式 胰岛素(人)
CAS:11061-68-0
木瓜蛋白酶 结构式 木瓜蛋白酶
CAS:9001-73-4
弹性酶 结构式 弹性酶
CAS:9004-06-2